Anti-HIV antibody and drug combinations exhibit synergistic activity against drug-resistant HIV-1 strains.
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.
Qianqian
Q
Qi
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China.
Qian
Q
Wang
Protein Interactions Group, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Weizao
W
Chen
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.
Fei
F
Yu
Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.
Lanying
L
Du
Protein Interactions Group, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Dimiter S
DS
Dimitrov
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: lul@fudan.edu.cn.
Lu
L
Lu
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College, Fudan University, Shanghai, China; Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA. Electronic address: shibojiang@fudan.edu.cn.
Shibo
S
Jiang
D019380:Anti-HIV Agents; D004338:Drug Combinations; D004357:Drug Synergism; D015483:HIV Antibodies; D015658:HIV Infections; D015497:HIV-1; D006801:Humans; D008826:Microbial Sensitivity Tests
D019380:Anti-HIV Agents; D004338:Drug Combinations; D015483:HIV Antibodies